- Home
- NKTX vs PZC Comparison
NKTX vs PZC Comparison
Compare NKTX & PZC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NKTX
- PZC
- Stock Information
- Founded
- NKTX 2015
- PZC 2002
- Country
- NKTX United States
- PZC United States
- Employees
- NKTX N/A
- PZC N/A
- Industry
- NKTX Biotechnology: Pharmaceutical Preparations
- PZC Investment Managers
- Sector
- NKTX Health Care
- PZC Finance
- Exchange
- NKTX Nasdaq
- PZC Nasdaq
- Market Cap
- NKTX 170.8M
- PZC 150.3M
- IPO Year
- NKTX 2020
- PZC N/A
- Fundamental
- Price
- NKTX $2.05
- PZC $6.86
- Analyst Decision
- NKTX Strong Buy
- PZC
- Analyst Count
- NKTX 5
- PZC 0
- Target Price
- NKTX $15.20
- PZC N/A
- AVG Volume (30 Days)
- NKTX 853.6K
- PZC 48.2K
- Earning Date
- NKTX 03-20-2025
- PZC 01-01-0001
- Dividend Yield
- NKTX N/A
- PZC 4.68%
- EPS Growth
- NKTX N/A
- PZC N/A
- EPS
- NKTX N/A
- PZC N/A
- Revenue
- NKTX N/A
- PZC N/A
- Revenue This Year
- NKTX N/A
- PZC N/A
- Revenue Next Year
- NKTX N/A
- PZC N/A
- P/E Ratio
- NKTX N/A
- PZC N/A
- Revenue Growth
- NKTX N/A
- PZC N/A
- 52 Week Low
- NKTX $1.96
- PZC $6.30
- 52 Week High
- NKTX $16.24
- PZC $8.20
- Technical
- Relative Strength Index (RSI)
- NKTX 39.74
- PZC 56.75
- Support Level
- NKTX $1.96
- PZC $6.77
- Resistance Level
- NKTX $2.35
- PZC $6.79
- Average True Range (ATR)
- NKTX 0.15
- PZC 0.06
- MACD
- NKTX -0.00
- PZC 0.01
- Stochastic Oscillator
- NKTX 19.15
- PZC 80.00
About NKTX Nkarta Inc.
Nkarta Inc is a biopharmaceutical company engaged in developing engineered natural killer (NK) cells to treat cancer and autoimmune diseases. The Company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer. The Company's operations are based in South San Francisco, California.
About PZC PIMCO California Municipal Income Fund III of Beneficial Interest
PIMCO CA Muni Income Fund III operates as a closed-end management investment company. The investment objective of the fund is to seek to provide current income exempt from federal and California income tax. Its portfolio of investments includes investment in different sectors such as education, healthcare, industrial and others.